Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: Results from a population-based case-control study

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 11, 2012, Pages 1173-1182

  Dublin, Sascha ^a,b   Walker, Rod L ^a   Jackson, Michael L ^a   Nelson, Jennifer C ^a,b   Weiss, Noel S ^b   Jackson, Lisa A ^a,b  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Antihypertensive agents; Case control studies; Pharmacoepidemiology; Pneumonia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

AGED; AMBULATORY CARE; ARTICLE; CASE CONTROL STUDY; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE SYSTEM; HOSPITAL PHARMACY; HOSPITALIZATION; HUMAN; IMMUNOCOMPETENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRESCRIPTION; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; IMMUNOCOMPETENCE; INTERNATIONAL CLASSIFICATION OF DISEASES; LISINOPRIL; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PNEUMONIA; RISK; WASHINGTON;

EID: 84868214510     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3340     Document Type: Article

References (23)

1. Kochanek KD, Xu J, Murphy SL, et al. Deaths: preliminary data for 2009. Natl Vital Stat Rep 2011; 59: 1-51.
2. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992; 117: 234-242.
3. Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. Am J Med 2010; 123: 1016-1030. DOI: 10.1016/j.amjmed.2010.06.014 S0002-9343(10)00571-1 [pii].
4. Morice AH, Lowry R, Brown MJ, et al. Angiotensin-converting enzyme and the cough reflex. Lancet 1987; 2: 1116-1118.
5. Ohkubo T, Chapman N, Neal B, et al. Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk. Am J Respir Crit Care Med 2004; 169: 1041-1045.
6. van de Garde EM, Souverein PC, van den Bosch JM, et al. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J 2006; 27: 1217-1222. DOI: 10.1183/09031936.06.00110005.
7. van de Garde EM, Souverein PC, Hak E, et al. Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes. J Hypertens 2007; 25: 235-239. DOI: 10.1097/HJH.0b013e328010520a 00004872-200701000-00032 [pii].
8. Myles PR, Hubbard RB, McKeever TM, et al. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf 2009; 18: 269-275. DOI: 10.1002/pds.1715.
9. Mukamal KJ, Ghimire S, Pandey R, et al. Antihypertensive medications and risk of community-acquired pneumonia. J Hypertens 2010; 28: 401-405. DOI:10.1097/HJH.0b013e3283330948.
10. Etminan M, Zhang B, Fitzgerald M, et al. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study. Pharmacotherapy 2006; 26: 479-482.
11. Okaishi K, Morimoto S, Fukuo K, et al. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients. Am J Hypertens 1999; 12: 778-783.
12. Takahashi T, Morimoto S, Okaishi K, et al. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene. Am J Hypertens 2005; 18: 1353-1359.
13. van de Garde EM, Oosterheert JJ, Bonten M, et al. International classification of diseases codes showed modest sensitivity for detecting community-acquired pneumonia. J Clin Epidemiol 2007; 60: 834-838. DOI: 10.1016/j.jclinepi.2006.10.018 S0895-4356(06)00421-5 [pii].
14. Aronsky D, Haug PJ, Lagor C, et al. Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual 2005; 20: 319-328. DOI:10.1177/1062860605280358 20/6/319 [pii].
15. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol 2004; 57: 131-141.
16. Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 2002; 40: 675-685.
17. Kieszak SM, Flanders WD, Kosinski AS, et al. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol 1999; 52: 137-142.
18. Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet 2008; 372: 398-405. DOI:10.1016/S0140-6736(08)61160-5.
19. Nelson JC, Jackson M, Yu O, et al. Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine 2008; 26: 4947-4954. DOI:10.1016/j.vaccine.2008.07.016 S0264-410X(08)00933-X [pii].
20. Saunders KW, Davis RL, Stergachis A. Group Health Cooperative. In Pharmacoepidemiology (4th edn), Strom BL (ed.). John Wiley & Sons: Chichester, 2005; 234.
21. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index 2012, December 19, 2011. http://www.whocc.no/atc_ddd_index/ [6 January 2012].
22. Dublin S, Jackson ML, Nelson JC, et al. Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ 2009; 338: b2137.
23. Dublin S, Walker RL, Jackson ML, et al. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study. Pharmacoepidemiol Drug Saf 2010; 19: 792-802. DOI:10.1002/pds.1978.